Inside Verily’s new strategy to expand clinical trial support

Hello,

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

• Verily's new president of research spoke to Insider about her new plan to expand clinical trial support;
• Peloton is rebranding itself as a corporate wellness company;
• Flu shots have gotten political since the COVID-19 pandemic. 

If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let's get to it…

---

How Amy Abernethy is rejiggering one of Verily's biggest bets to change clinical research and propel the Google spin-off into the future

• The Google spin-off Verily is looking to expand its clinical-trials business.
• Dr. Amy Abernethy, Verily's new president of research, shared the vision for 2022 in an interview.
• The venture will sell more trial tools but also build a massive data resource to help drugmakers.

Read more now>>

---

Peloton's been hit hard as interest in home exercise drops. Here's why it's starting to sell its services to companies like Samsung and UnitedHealthcare.

• Peloton's stock price is underperforming investors' expectations after pandemic highs.
• One revenue stream the company is considering is its young corporate-wellness arm.
• Peloton provides benefits to companies like Samsung and thinks its community gives it an edge.

Check it out>>

---

The gap between Republicans and Democrats on flu shots is 20 percentage-points bigger than it was pre-pandemic

• Recent polls show a 25 percentage-point gap between Republicans and Democrats who've gotten or will get a flu shot.
• This is remarkably similar to the approximately 30 percentage-point partisan gap on COVID-19 vaccine uptake.
• Prior to the COVID-19 pandemic, there was little to no partisan gap on influenza vaccine uptake. 

Dive in>> 

---

More stories we're reading:

• We asked 9 of Europe's top healthcare investors which areas would affect the industry most amid record VC funding (Insider)
• A company in the UK will soon start clinical trials of a vaccine patch that could stimulate T-cell immunity (The Guardian)
• Goop threw a cruise, and no Goopies came (Insider)
• Scientists have found a second person who has been 'naturally' cured of HIV (STAT News)

---

-Leah